Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease

Karlijn J Doorn, Paul J Lucassen, Hendrikus W Boddeke, Marloes Prins, Henk W Berendse, Benjamin Drukarch, Anne-Marie van Dam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Recent data has indicated that the traditional view of Parkinson's disease (PD) as an isolated disorder of the nigrostriatal dopaminergic system alone is an oversimplification of its complex symptomatology. Aside from classical motor deficits, various non-motor symptoms including autonomic dysfunction, sensory and cognitive impairments as well as neuropsychiatric alterations and sleep disturbances are common in PD. Some of these non-motor symptoms can even antedate the motor problems. Many of them are associated with extranigral neuropathological changes, such as extensive α-synuclein pathology and also neuroinflammatory responses in specific brain regions, i.e. microglial activation, which has been implicated in several aspects of PD pathogenesis and progression. However, microglia do not represent a uniform population, but comprise a diverse group of cells with brain region-specific phenotypes that can exert beneficial or detrimental effects, depending on the local phenotype and context. Understanding how microglia can be neuroprotective in one brain region, while promoting neurotoxicity in another, will improve our understanding of the role of microglia in neurodegeneration in general, and of their role in PD pathology in particular. Since neuroinflammatory responses are in principle modifiable, such approaches could help to identify new targets or adjunctive therapies for the full spectrum of PD-related symptoms.

Original languageEnglish
Pages (from-to)222-238
Number of pages17
JournalProgress in Neurobiology
Volume98
Issue number2
DOIs
Publication statusPublished - 2012

Cite this

Doorn, Karlijn J ; Lucassen, Paul J ; Boddeke, Hendrikus W ; Prins, Marloes ; Berendse, Henk W ; Drukarch, Benjamin ; van Dam, Anne-Marie. / Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. In: Progress in Neurobiology. 2012 ; Vol. 98, No. 2. pp. 222-238.
@article{ca3a0a3584f948b2902ce512e9061ae2,
title = "Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease",
abstract = "Recent data has indicated that the traditional view of Parkinson's disease (PD) as an isolated disorder of the nigrostriatal dopaminergic system alone is an oversimplification of its complex symptomatology. Aside from classical motor deficits, various non-motor symptoms including autonomic dysfunction, sensory and cognitive impairments as well as neuropsychiatric alterations and sleep disturbances are common in PD. Some of these non-motor symptoms can even antedate the motor problems. Many of them are associated with extranigral neuropathological changes, such as extensive α-synuclein pathology and also neuroinflammatory responses in specific brain regions, i.e. microglial activation, which has been implicated in several aspects of PD pathogenesis and progression. However, microglia do not represent a uniform population, but comprise a diverse group of cells with brain region-specific phenotypes that can exert beneficial or detrimental effects, depending on the local phenotype and context. Understanding how microglia can be neuroprotective in one brain region, while promoting neurotoxicity in another, will improve our understanding of the role of microglia in neurodegeneration in general, and of their role in PD pathology in particular. Since neuroinflammatory responses are in principle modifiable, such approaches could help to identify new targets or adjunctive therapies for the full spectrum of PD-related symptoms.",
keywords = "Animals, Humans, Microglia, Parkinson Disease, Journal Article, Research Support, Non-U.S. Gov't, Review",
author = "Doorn, {Karlijn J} and Lucassen, {Paul J} and Boddeke, {Hendrikus W} and Marloes Prins and Berendse, {Henk W} and Benjamin Drukarch and {van Dam}, Anne-Marie",
note = "Copyright {\circledC} 2012 Elsevier Ltd. All rights reserved.",
year = "2012",
doi = "10.1016/j.pneurobio.2012.06.005",
language = "English",
volume = "98",
pages = "222--238",
journal = "Progress in Neurobiology",
issn = "0301-0082",
publisher = "Elsevier Limited",
number = "2",

}

Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. / Doorn, Karlijn J; Lucassen, Paul J; Boddeke, Hendrikus W; Prins, Marloes; Berendse, Henk W; Drukarch, Benjamin; van Dam, Anne-Marie.

In: Progress in Neurobiology, Vol. 98, No. 2, 2012, p. 222-238.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease

AU - Doorn, Karlijn J

AU - Lucassen, Paul J

AU - Boddeke, Hendrikus W

AU - Prins, Marloes

AU - Berendse, Henk W

AU - Drukarch, Benjamin

AU - van Dam, Anne-Marie

N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.

PY - 2012

Y1 - 2012

N2 - Recent data has indicated that the traditional view of Parkinson's disease (PD) as an isolated disorder of the nigrostriatal dopaminergic system alone is an oversimplification of its complex symptomatology. Aside from classical motor deficits, various non-motor symptoms including autonomic dysfunction, sensory and cognitive impairments as well as neuropsychiatric alterations and sleep disturbances are common in PD. Some of these non-motor symptoms can even antedate the motor problems. Many of them are associated with extranigral neuropathological changes, such as extensive α-synuclein pathology and also neuroinflammatory responses in specific brain regions, i.e. microglial activation, which has been implicated in several aspects of PD pathogenesis and progression. However, microglia do not represent a uniform population, but comprise a diverse group of cells with brain region-specific phenotypes that can exert beneficial or detrimental effects, depending on the local phenotype and context. Understanding how microglia can be neuroprotective in one brain region, while promoting neurotoxicity in another, will improve our understanding of the role of microglia in neurodegeneration in general, and of their role in PD pathology in particular. Since neuroinflammatory responses are in principle modifiable, such approaches could help to identify new targets or adjunctive therapies for the full spectrum of PD-related symptoms.

AB - Recent data has indicated that the traditional view of Parkinson's disease (PD) as an isolated disorder of the nigrostriatal dopaminergic system alone is an oversimplification of its complex symptomatology. Aside from classical motor deficits, various non-motor symptoms including autonomic dysfunction, sensory and cognitive impairments as well as neuropsychiatric alterations and sleep disturbances are common in PD. Some of these non-motor symptoms can even antedate the motor problems. Many of them are associated with extranigral neuropathological changes, such as extensive α-synuclein pathology and also neuroinflammatory responses in specific brain regions, i.e. microglial activation, which has been implicated in several aspects of PD pathogenesis and progression. However, microglia do not represent a uniform population, but comprise a diverse group of cells with brain region-specific phenotypes that can exert beneficial or detrimental effects, depending on the local phenotype and context. Understanding how microglia can be neuroprotective in one brain region, while promoting neurotoxicity in another, will improve our understanding of the role of microglia in neurodegeneration in general, and of their role in PD pathology in particular. Since neuroinflammatory responses are in principle modifiable, such approaches could help to identify new targets or adjunctive therapies for the full spectrum of PD-related symptoms.

KW - Animals

KW - Humans

KW - Microglia

KW - Parkinson Disease

KW - Journal Article

KW - Research Support, Non-U.S. Gov't

KW - Review

U2 - 10.1016/j.pneurobio.2012.06.005

DO - 10.1016/j.pneurobio.2012.06.005

M3 - Article

VL - 98

SP - 222

EP - 238

JO - Progress in Neurobiology

JF - Progress in Neurobiology

SN - 0301-0082

IS - 2

ER -